A UCLA-Providence study found that new-onset rates of chronic kidney disease (CKD) in people with diabetes were highest among racial and ethnic minority groups compared to whites.
The study, published as a letter to the editors of the New England Journal of Medicine, found that Native Hawaiian/Pacific Islander blacks had approximately 60%, 40%, 33%, and 25% higher rates of new-onset CKD. understood. Native American/Alaskan Native and Hispanic/Latino populations, respectively, compared with Caucasians with diabetes.
CKD continues to have a high incidence in diabetes, although its proportion declined from 8% of the total diabetic population in 2015-2016 to 6.4% in 2019-2020. “
“Our findings provide a targeted approach aimed at intentionally altering the trajectory of persistently high rates of diabetes-related CKD and renal failure that disproportionately affect racial and ethnic minority groups. It constitutes a call to action to initiate targeted efforts,” said co-author Dr. Susanne Nicholas, UCLA She is Associate Professor in the Department of Nephrology at the David Geffen School of Medicine and Chair of the UCLA Nephrology Racial and Health Equity Committee.
The first step is to increase screening and detection of CKD in diabetic patients. “
Susanne Nicholas, Ph.D., co-author and associate professor of medicine, University of California, Los Angeles, David Geffen School of Medicine, Nephrology, Division of Nephrology, School of Medicine
Researchers at The Geffen School, Providence, and the Centers for Disease Control and Prevention tracked 654,549 people with diabetes from 2015 to 2020 using electronic health records from Providence Health and UCLA Health. .
The prevalence of kidney failure requiring dialysis or transplantation doubled to nearly 800,000 in the United States between 2000 and 2019, with diabetes being the leading cause. Although the incidence of new incidence of CKD in people with diabetes was previously unknown, the value of such incidence data could be used to identify at-risk populations, determine the efficacy of interventions, and improve healthcare delivery and public health. Essential for assessing impact on response. Even more striking, less than 10% of patients with early-stage renal disease recognize CKD at this stage of progression, when treatment is most effective.
“Given the rapidly increasing prevalence of diabetes in the United States and the corresponding high incidence of renal failure, there is a persistently high incidence of CKD characterized by racial and ethnic disparities. is a problem,” says lead author Catherine Tuttle, Ph.D., professor of medicine at Providence Inland Northwest Health and the University of Washington. “Comprehensive strategies for prevention, detection, and intervention are needed to reduce CKD risk in people with diabetes.”
Additional study authors are Dr. O. Kenrik Duru and Dr. Keith Norris of UCLA. Kami Jones, Ken Dalasa, Dr. Radhika Alisik and Joshua Neumiller of Providence. Dr. Nilka Rios Burroughs, Alan Koyama, and Meda Pavkov of the Centers for Disease Control and Prevention.
